Patent Assignment
Reel/Frame 057748/0450
Assignment of Assignor's Interest
Recorded: 2021-10-07
Pages: 3
Assignee
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) CO., LTD.
BUILDING #15, LANE 1000, ZHANGHENG ROAD, PUDONG NEW DISTRICT, SHANGHAI, 201203, CHINA
Covered Property
(1)
Recombinant Fusion Proteins Targeting CD47 and Pd-L1, Preparation and Use Thereof
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.